BioCentury
ARTICLE | Company News

Avant to acquire Megan Health

November 21, 2000 8:00 AM UTC

AVAN will purchase vaccine company Megan Health (St. Louis, Mo.) for 1.9 million AVAN shares valued at about $18 million. AVAN said the acquisition adds to its vaccines portfolio, including technology...